R

Respiri Ltd
ASX:RSH

Watchlist Manager
Respiri Ltd
ASX:RSH
Watchlist
Price: 0.076 AUD -5%
Market Cap: 100.8m AUD
Have any thoughts about
Respiri Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Respiri Ltd

Revenue
1m AUD
Cost of Revenue
-3.9k AUD
Gross Profit
1m AUD
Operating Expenses
-8.1m AUD
Operating Income
-7.1m AUD
Other Expenses
-74.8k AUD
Net Income
-7.1m AUD

Margins Comparison
Respiri Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Respiri Ltd
ASX:RSH
100.8m AUD
100%
-679%
-686%
US
Abbott Laboratories
NYSE:ABT
196.3B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.3B USD
67%
26%
29%
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
69%
18%
11%
US
Stryker Corp
NYSE:SYK
137.6B USD
64%
22%
16%
IE
Medtronic PLC
NYSE:MDT
104.9B USD
65%
19%
13%
US
Becton Dickinson and Co
NYSE:BDX
68.3B USD
45%
14%
9%
DE
Siemens Healthineers AG
XETRA:SHL
56.8B EUR
38%
13%
9%
US
Edwards Lifesciences Corp
NYSE:EW
41.9B USD
79%
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39B USD
41%
13%
9%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
283.9B CNY
64%
36%
33%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Respiri Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Respiri Ltd
ASX:RSH
100.8m AUD
-412%
-152%
-380%
-301%
US
Abbott Laboratories
NYSE:ABT
196.3B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.3B USD
16%
14%
14%
19%
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
9%
5%
9%
7%
US
Stryker Corp
NYSE:SYK
137.6B USD
19%
9%
14%
11%
IE
Medtronic PLC
NYSE:MDT
104.9B USD
9%
5%
8%
7%
US
Becton Dickinson and Co
NYSE:BDX
68.3B USD
7%
3%
6%
5%
DE
Siemens Healthineers AG
XETRA:SHL
56.8B EUR
11%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
41.9B USD
51%
37%
16%
18%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39B USD
22%
5%
10%
7%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
283.9B CNY
33%
22%
30%
37%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.